HOTH
NASDAQ · Pharmaceuticals
Hoth Therapeutics Inc
$0.75
-0.04 (-5.23%)
Open$0.81
Previous Close$0.79
Day High$0.83
Day Low$0.75
52W High$2.45
52W Low$0.49
Volume—
Avg Volume507.8K
Market Cap30.69M
P/E Ratio—
EPS$-0.81
SectorPharmaceuticals
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 4.55M | 4.47M | 5.09M |
| Net Income | 883.9K | 919.3K | 807.7K |
| Profit Margin | 19.4% | 20.6% | 15.9% |
| EBITDA | 1.12M | 1.15M | 1.14M |
| Free Cash Flow | 1.08M | 1.03M | 790.7K |
| Rev Growth | +13.3% | +17.8% | +20.0% |
| Debt/Equity | 0.67 | 0.60 | 0.55 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,170.14 | +0.45% | 40.7 | 1.09T |
| JNJ | Johnson & Johnson | $269.19 | -0.10% | 30.6 | 644.12B |
| MRK | Merck & Co. Inc. | $150.91 | +0.94% | 114.0 | 361.66B |
| PFE | Pfizer Inc. | $27.93 | +0.68% | 36.4 | 157.54B |
| BMY | Bristol-Myers Squibb Co | $62.25 | -0.59% | 13.9 | 128.81B |
| ZTS | Zoetis Inc | $72.86 | +2.15% | 11.5 | 30.15B |